Novo Nordisk expects drugs excluded from sanctions against Russia

Danish pharmaceutical firm Novo Nordisk is concerned for its employees in Ukraine as Russian forces invade the country from multiple fronts (Corrected)

Photo: Novo Nordisk / PR

(Corrected at 16.29 - It was stated earlier in the article that Novo Nordisk has not closed its office in the capital Kiev. This is not correct. As of Thursday the office is closed, the pharmaceutical company informs MedWatch. MedWatch apologizes for the error.)

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

Further reading

Related articles

Latest news

See all jobs